Dallas-based Financial Strategies Acquisition Corp. has acquired Texas-based preclinical pharmaceutical company Austin Biosciences Corp.
Financial Strategies is a special purpose acquisition company led by CEO Alexander V. Schinzing. It said that upon the deal’s closing, Austin Biosciences will become a wholly owned subsidiary of the company.
Earlier this month, Financial Strategies announced that its board approved an extension of the period of time available to consummate the deal by one month from Feb. 14 to March 14. The company said the purpose of the extension is to provide additional time to complete its initial business combination.
Schinzing will serve as chairman and Dr. Burgi-Krishnamurthy will serve as chief executive officer of Austin Biosciences.
“Austin Biosciences patent-protected technology is designed to improve therapies to treat cancer. The drug can cross the blood brain barrier and actively target cancer cells, reducing human suffering and saving lives. We are looking forward to becoming part of this exciting future,” Schinzing said in a statement.
“The business combination of Financial Strategies Acquisition Corp. and Austin Biosciences allows us to advance the preclinical development of our platform technology, to add significant experience to the Austin Biosciences board of directors and to access high-quality institutional investors,” Burgi-Krishnamurthy said in a statement.
Austin Biosciences is a preclinical pharmaceutical company with multiple, proprietary product candidates derived from an innovative nanotechnology-based approach to drug development.
The company said that approach strives to enhance the bioavailability, effectiveness and reduce the toxicity of crucial FDA-licensed pharmaceutical API (Active Pharmaceutical Ingredients).
Austin Biosciences said its product candidates seek to improve existing licensed product into safer and more effective drug therapies.
Product candidates focus upon the development of improvements to existing FDA approved cancer treatment therapies to make them more bioavailable, less toxic and more soluble, the company said.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
“Millennials and Gen Z are reinventing investing," says Zogo founder Bolun Li. The company's next-gen financial education takes a Gen Z approach to covering financial literacy—gamification.
-
Westlake-based Charles Schwab has partnered with Girls Scouts USA to modernize and relaunch the organization's financial literacy badges. The new financial literacy curriculum includes topics such as investing basics, building wealth, entrepreneurship, fraud awareness, and budgeting for different goals throughout life. The goal is to help bridge the gap between what girls learn in school and what they need to feel confident managing finances in life and business,.
-
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Exela Technologies, Newmark, OrangeGrid, RailPros, Aimbridge Hospitality, Integrity Marketing Group, Smoothie King, Bank of Texas, MD7, Salvation Army, and more. Plus, you'll find board appointments including Texas Mutual Insurance, Zimperium, and the Ebby Halliday Foundation.
-
"Gifting is about more than passing down wealth—it's about passing down purpose." Susan Hirshman Director of Wealth Management Schwab Wealth Advisory and Schwab Center for Financial Research ...on the motivations behind high net worth gifting, via Schwab's latest HNW Client Pulse Survey. Despite market volatility and economic uncertainty in early 2025, high net worth investors aren't pulling back on their wealth transfer plans. That's according to Schwab's latest client pulse survey, which shows 51% of clients with at least $1 million in assets plan to gift some of their wealth this year. As Schwab's Susan Hirshman notes, it's not just…
-
Donna Guy brings more than 25 years of experience in financial leadership across public and private companies to her new position.
